Management Inc. Altiva serves as Executive at PROGENICS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Management Inc. Altiva has executed 1 insider transactions totaling $359.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 9, 2019 involved purchasing 72,023 shares valued at $359.4K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 9, 2019 | PGNX | $359.4K | Purchase | 72,023 | $4.99 | Discretionary |
Management Inc. Altiva currently holds 8,011,733 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Management Inc. Altiva has been a net buyer of PGNX stock. They have purchased $359.4K and sold $0 worth of shares.
Management Inc. Altiva's most recent insider trade was on Sep 9, 2019, when they purchased 72,023 shares at $4.99 per share.
Get notified when new Form 4 filings are submitted